Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Finding treatments faster

      In March, Action on Hearing Loss gathered experts from across the world to discuss ways to accelerate the development of treatments for hearing disorders.

      TRIH Summit 2018

      According to a recent report from the World Health Organization, 466 million people in the world have disabling hearing loss and 1.1 billion young people (12-35 years old) are at risk of losing their hearing due to recreational noise (WHO, 2018).

      As the world’s largest, donor-funded research programme dedicated to finding treatments for hearing loss and tinnitus, the biomedical research team at Action on Hearing Loss teamed up with the University College London (UCL) Ear Institute and the National Institute for Health Research (NIHR) to gather 159 experts in hearing loss from across the world at a summit in London, on the 22nd March. We invited experts from universities, biotechnology and pharmaceutical companies, investors, commissioners, clinicians and patients to talk about the biggest challenges and opportunities in hearing loss research and discuss how to speed up the development of treatments for hearing loss and tinnitus.

      At the summit, the attendees heard about the latest exciting developments in research and clinical trials. Highlights included Novartis, one of the largest pharmaceutical companies in the world, sharing the progression of a gene therapy to regenerate hearing that Novartis is currently testing in people. Fennec Pharmaceuticals presented the successful results of their Phase 3 trial, the last stage of testing in people before being licensed to be used in the clinic. Fennec has shown that their therapy successfully protects the hearing of children who undergo chemotherapy treatments with drugs that damage the cells in the inner ear.

      16 companies and researchers from around the world presented their work focussing on the development of different treatments to protect or regenerate hearing. The summit ended with a round table discussion between eight experts and the audience in the room about how can we all contribute to speed up the development of treatments for hearing disorders.

      Find out more

      We depend on your donations so we can fund the best hearing and tinnitus research around the world. Donate today and help us continue our vital work into hearing treatments, so that people can live life to the full again.

      If you want to have a sneak peek at the summit and hear the opinion of Dr Steven Holtzman, President & CEO of Decibel Therapeutics, a US-based company developing treatments for different forms of hearing loss; Hugh Strickland, Corporate Finance Partner at Aaron & Partners, who has hereditary hearing loss, and Dr Ralph Holme, Executive Director of Research at Action on Hearing Loss, watch the summit highlights

      A specialized report that summarizes the discussions of the day and proposes some of the changes that need to be implemented to accelerate the development of treatments can be found on the same page on the right hand side.

      By: Dr Tracey Pollard | 14 June 2018

      Summit Report

      Download the report of the summit.

      Download

      Recent Posts

      Scientifically speaking...

      We funded Dr Helen Willis’s PhD research assessing ‘listening effort’ for people using a cochlear implant. It’s a subject close to Helen’s heart, as she’s an implant user.

      By: Dr Helen Willis
      13 December 2018

      A Christmas story of travelling with hearing loss

      The Deaf Traveller tells his tale of travelling with hearing loss to get home for Christmas on a train that he’s not sure where it is going. This is because the train does not have the right deaf awareness or effective communication tools for the 1 in 6 people in the UK with some form of hearing loss. Luckily, a Christmas miracle soon appears to ensure he has a stress-free journey home.

      By: Edward Rex
      12 December 2018

      Tribute to Professor Maria Bitner-Glindzicz

      Professor Maria Bitner-Glindzicz, a world-leading clinical geneticist at UCL, whose work helped families to understand the causes of their hearing loss, tragically died following an accident in September. As a tribute to her, we reflect on her contribution to hearing research.

      By: Action on Hearing Loss
      12 December 2018

      Regenerating hair cells – another piece of the puzzle

      Hair cells are crucial for our ability to hear, but we still don’t know exactly how they develop in the inner ear, or all the genes and processes that combine to make sure they work correctly. New research that we funded has shed light on how one particular gene is involved – Tracey Pollard from our research team explains more.

      By: Tracey Pollard
      11 December 2018

      Recent Posts

      Scientifically speaking...

      We funded Dr Helen Willis’s PhD research assessing ‘listening effort’ for people using a cochlear implant. It’s a subject close to Helen’s heart, as she’s an implant user.

      By: Dr Helen Willis
      13 December 2018

      A Christmas story of travelling with hearing loss

      The Deaf Traveller tells his tale of travelling with hearing loss to get home for Christmas on a train that he’s not sure where it is going. This is because the train does not have the right deaf awareness or effective communication tools for the 1 in 6 people in the UK with some form of hearing loss. Luckily, a Christmas miracle soon appears to ensure he has a stress-free journey home.

      By: Edward Rex
      12 December 2018

      Tribute to Professor Maria Bitner-Glindzicz

      Professor Maria Bitner-Glindzicz, a world-leading clinical geneticist at UCL, whose work helped families to understand the causes of their hearing loss, tragically died following an accident in September. As a tribute to her, we reflect on her contribution to hearing research.

      By: Action on Hearing Loss
      12 December 2018

      Regenerating hair cells – another piece of the puzzle

      Hair cells are crucial for our ability to hear, but we still don’t know exactly how they develop in the inner ear, or all the genes and processes that combine to make sure they work correctly. New research that we funded has shed light on how one particular gene is involved – Tracey Pollard from our research team explains more.

      By: Tracey Pollard
      11 December 2018

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.